}Chronic Hepatitis C
•Pegasys is indicated for the treatment of chronic hepatitis C in adults patients who are positive for serum HCV-RNA, including patients with
compensated cirrhosis and or co-infected
with clinically stable HIV.
}Chronic Hepatitis B
•Pegasys is indicated for the treatment of both HBeAg-positive and HBeAg-negatiev chronic hepatitis B in non-cirrhotic and cirrhotic adult patients with compensated liver disease and evidence of viral replication and liver inflammation